High-expression of DJ-1 and loss of PTEN associated with tumor metastasis and correlated with poor prognosis of gastric carcinoma

International Journal of Medical Sciences

Volumn 10, Issue 12, 2013, Pages 1689-1697

  Li, Yin ^a   Cui, Ji ^a   Zhang, Chang Hua ^a   Yang, Dong Jie ^a   Chen, Jian Hui ^a   Zan, Wen Hua ^a   Li, Bin ^a   Li, Zhi ^a   He, Yu Long ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

DJ 1; Gastric carcinoma; Metastasis; Prognosis; PTEN

Indexed keywords

DJ 1 PROTEIN; FLUOROURACIL; FOLINIC ACID; OXALIPLATIN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE;

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CONTINUOUS INFUSION; CONTROLLED STUDY; DISTANT METASTASIS; DOWN REGULATION; FEMALE; GASTRECTOMY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS; OVERALL SURVIVAL; PROGNOSIS; PROTEIN EXPRESSION; STOMACH CARCINOMA; TISSUE MICROARRAY;

DJ-1; GASTRIC CARCINOMA; METASTASIS; PROGNOSIS.; PTEN;

AGED; CARCINOMA; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; ONCOGENE PROTEINS; PARAFFIN EMBEDDING; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PTEN PHOSPHOHYDROLASE; STOMACH NEOPLASMS;

EID: 84884567714     PISSN: 14491907     EISSN: None     Source Type: Journal    
DOI: 10.7150/ijms.7292     Document Type: Article

References (39)

1. Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002. CA Cancer J Clin. 2005; 55:74-108.
2. Roder DM. The epidemiology of gastric cancer. Gastric Cancer. 2002; 5:5-11.
3. Yoo CB, Jones PA. Epigenetic therapy of cancer: past, present and future. Nat Rev Drug Discov. 2006; 5:37-50.
4. Zheng L, Wang L, Ajani J, et al. Molecular basis of gastric cancer development and progression. Gastric Cancer. 2004; 7:61-77.
5. Maehama T, Dixon JE. The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate. J Biol Chem. 1998; 273:13375-8.
6. Stambolic V, Suzuki A, de la Pompa JL, et al. Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN. Cell. 1998; 95:29-39.
7. Mukhopadhyay UK, Mooney P, Jia L, et al. Doubles game: Src-Stat3 versus p53-PTEN in cellular migration and invasion. Mol Cell Biol. 2010; 30:4980-95.
8. Nogueira C, Kim KH, Sung H, et al. Cooperative interactions of PTEN deficiency and RAS activation in melanoma metastasis. Oncogene. 2010; 29:6222-32.
9. Waite KA, Eng C. Protean PTEN: form and function. Am J Hum Genet. 2002; 70:829-44.
10. Lee H, Choi SK, Ro JY. Overexpression of DJ-1 and HSP90α, and loss of PTEN associated with invasive urothelial carcinoma of urinary bladder: Possible prognostic markers. Oncol Lett. 2012; 3:507-12.
11. Kang YH, Lee HS, Kim WH. Promoter methylation and silencing of PTEN in gastric carcinoma. Lab Invest. 2002; 82:285-91.
12. Zhu X, Qin X, Fei M, et al. Loss and reduced expression of PTEN correlate with advanced-stage gastric carcinoma. Exp Ther Med. 2013; 5:57-64.
13. Liu H, Wang M, Li M, et al. Expression and role of DJ-1 in leukemia. Biochem Biophys Res Commun. 2008; 375:477-83.
14. Arnouk H, Merkley MA, Podolsky RH, et al. Characterization of molecular markers indicative of cervical cancer progression. Proteomics Clin Appl. 2009; 3:516-27.
15. Liu S, Yang Z, Wei H, et al. Increased DJ-1 and its prognostic significance in hepatocellular carcinoma. Hepatogastroenterology. 2010; 57:1247-56.
16. Zhu XL, Wang ZF, Lei WB, et al. DJ-1: a novel independent prognostic marker for survival in glottic squamous cell carcinoma. Cancer Sci. 2010; 101:1320-5.
17. Kim RH, Peters M, Jang Y, et al. DJ-1, a novel regulator of the tumor suppressor PTEN. Cancer Cell. 2005; 7:263-73.
18. Tian M, Cui YZ, Song GH, et al. Proteomic analysis identifies MMP-9, DJ-1 and A1BG as overexpressed proteins in pancreatic juice from pancreatic ductal adenocarcinoma patients. BMC Cancer. 2008,8:241.
19. Le Naour F, Misek DE, Krause MC, et al. Proteomics-based identification of RS/DJ-1 as a novel circulating tumor antigen in breast cancer. Clin Cancer Res. 2001; 7:3328-35.
20. Shimwell NJ, Ward DG, Mohri Y, et al. Macrophage migration inhibitory factor and DJ-1 in gastric cancer: differences between high-incidence and low-incidence areas. Br J Cancer. 2012; 107:1595-601.
21. Lauwers GY, Carneiro F, Graham DY, et al. Gastric carcinoma. In: Bosman FT, Carneiro F, Hruban RH, et al, eds. WHO classification of tumors of the digestive system. Lyon: IARC; 2010: 48-58.
22. Edge SB, Byrd DR, Compton CC, et al. AJCC cancer staging manual (7th edition). New York, USA: Springer; 2010.
23. Kallioniemi OP, Wagner U, Kononen J, et al. Tissue microarray technology for high-throughput molecular profiling of cancer. Hum Mol Genet. 2001; 10:657-62.
24. MacKeigan JP, Clements CM, Lich JD, et al. Proteomic profiling drug-induced apoptosis in non-small cell lung carcinoma: identification of RS/DJ-1 and RhoGDIalpha. Cancer Res. 2003; 63:6928-34.
25. Oda M, Makita M, Iwaya K, et al. High levels of DJ-1 protein in nipple fluid of patients with breast cancer. Cancer Sci. 2012; 103:1172-6.
26. He XY, Liu BY, Yao WY, et al. Serum DJ-1 as a diagnostic marker and prognostic factor for pancreatic cancer. J Dig Dis. 2011; 12:131-7.
27. Yuen HF, Chan YP, Law S, et al. DJ-1 could predict worse prognosis in esophageal squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev. 2008; 17:3593-602.
28. Fan J, Ren H, Jia N, et al. DJ-1 decreases Bax expression through repressing p53 transcriptional activity. J Biol Chem. 2008; 283:4022-30.
29. Clements CM, McNally RS, Conti BJ, et al. DJ-1, a cancer- and Parkinson's disease-associated protein, stabilizes the antioxidant transcriptional master regulator Nrf2. Proc Natl Acad Sci USA. 2006; 103:15091-6.
30. Geiger TR, Peeper DS. Metastasis mechanisms. Biochim Biophys Acta. 2009; 1796:293-308.
31. Pardo M, García A, Thomas B, et al. The characterization of the invasion phenotype of uveal melanoma tumour cells shows the presence of MUC18 and HMG-1 metastasis markers and leads to the identification of DJ-1 as a potential serum biomarker. Int J Cancer. 2006; 119:1014-22.
32. He X, Zheng Z, Li J, et al. DJ-1 promotes invasion and metastasis of pancreatic cancer cells by activating SRC/ERK/uPA. Carcinogenesis. 2012; 33:555-62.
33. Bignell GR, Greenman CD, Davies H, et al. Signatures of mutation and selection in the cancer genome. Nature. 2010; 463:893-8.
34. Carracedo A, Alimonti A, Pandolfi PP. PTEN level in tumor suppression: how much is too little? Cancer Res. 2011; 71:629-33.
35. Alessi DR, James SR, Downes CP, et al. Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Balpha. Curr Biol. 1997; 7:261-9.
36. Song G, Ouyang G, Bao S. The activation of Akt/PKB signaling pathway and cell survival. J Cell Mol Med. 2005; 9:59-71.
37. Yang Y, Gehrke S, Haque ME, et al. Inactivation of Drosophila DJ-1 leads to impairments of oxidative stress response and phosphatidylinositol 3-kinase/Akt signaling. Proc Natl Acad Sci USA. 2005; 102:13670-5.
38. Aleyasin H, Rousseaux MW, Marcogliese PC, et al. DJ-1 protects the nigrostriatal axis from the neurotoxin MPTP by modulation of the AKT pathway. Proc Natl Acad Sci USA. 2010; 107:3186-91.
39. Kim BS, Cho SW, Min SK, et al. Differences in prognostic factors between early and advanced gastric cancer. Hepatogastroenterology. 2011; 58:1032-40.